Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
40.90
-0.40 (-0.97%)
Mar 5, 2026, 5:00 PM CET
Market Cap758.08M -9.9%
Revenue (ttm)373.90M +11.8%
Net Income-2.89M
EPS-0.16
Shares Out18.36M
PE Ration/a
Forward PE47.47
Dividendn/a
Ex-Dividend Daten/a
Volume27,205
Average Volume18,924
Open41.30
Previous Close41.30
Day's Range40.10 - 41.60
52-Week Range26.50 - 49.40
Beta-0.03
RSI40.05
Earnings DateMar 31, 2026

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 969
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements